Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.

Ali S, Bolinger AA, Zhou J

DOI: 10.2174/0115680266300245240223070242
Published: 2024
Container: Current topics in medicinal chemistry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/0115680266300245240223070242,
  title = {Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.},
  author = {Ali S and Bolinger AA and Zhou J},
  year = {2024},
  journal = {Current topics in medicinal chemistry},
  doi = {10.2174/0115680266300245240223070242},
  url = {https://doi.org/10.2174/0115680266300245240223070242}
}

RIS

TY  - JOUR
TI  - Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.
AU  - Ali S
AU  - Bolinger AA
AU  - Zhou J
PY  - 2024
JO  - Current topics in medicinal chemistry
DO  - 10.2174/0115680266300245240223070242
UR  - https://doi.org/10.2174/0115680266300245240223070242
ER  -

APA

S, A., AA, B., & J, Z. (2024). Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.. Current topics in medicinal chemistry. https://doi.org/10.2174/0115680266300245240223070242

Source records

pubmed · retrieved 2026-09-26T11:30:51.340Z
europe-pmc · retrieved 2026-09-26T11:30:51.336Z